{"id":"NCT00808132","sponsor":"Pfizer","briefTitle":"Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis","officialTitle":"A Double-Blind, Randomized, Placebo And Active- Controlled Efficacy And Safety Study Of The Effects Of Bazedoxifene/Conjugated Estrogens Combinations On Endometrial Hyperplasia And Prevention Of Osteoporosis In Postmenopausal Women","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-01","primaryCompletion":"2011-02","completion":"2011-02","firstPosted":"2008-12-15","resultsPosted":"2013-12-20","lastUpdate":"2014-04-08"},"enrollment":1886,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Menopause","Osteoporosis"],"interventions":[{"type":"DRUG","name":"bazedoxifene 20 mg/ conjugated estrogens 0.45 mg","otherNames":[]},{"type":"DRUG","name":"bazedoxifene 20 mg/ conjugated estrogens 0.625 mg","otherNames":[]},{"type":"DRUG","name":"bazedoxifene 20 mg","otherNames":[]},{"type":"DRUG","name":"conjugated estrogens 0.45 mg/ medroxyprogesterone acetate 1.5 mg","otherNames":["Prempro"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"EXPERIMENTAL"},{"label":"4","type":"ACTIVE_COMPARATOR"},{"label":"5","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this research study is to evaluate the safety and effectiveness of this investigational drug for the treatment of menopausal symptoms while protecting the endometrium (uterine lining) and preventing postmenopausal osteoporosis. Subject participation will last approximately 14.5 months.","primaryOutcome":{"measure":"Percentage of Participants With Endometrial Hyperplasia at Month 12: Main Study","timeFrame":"Month 12","effectByArm":[{"arm":"Bazedoxifene 20 mg / Conjugated Estrogens 0.45 mg","deltaMin":0.3,"sd":null},{"arm":"Bazedoxifene 20 mg / Conjugated Estrogens 0.625 mg","deltaMin":0.54,"sd":null},{"arm":"Bazedoxifene 20 mg","deltaMin":0,"sd":null},{"arm":"Conjugated Estrogens 0.45mg/Medroxyprogesterone Acetate 1.5mg","deltaMin":0,"sd":null},{"arm":"Placebo","deltaMin":0.85,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":178,"countries":["United States","Argentina","Australia","Chile","Colombia","Denmark","Finland","Hungary","Mexico","New Zealand","Norway","Poland"]},"refs":{"pmids":["24438370","23635731"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=3115A1-3307&StudyName=Study%20Evaluating%20The%20Effects%20Of%20Bazedoxifene/Conjugated%20Estrogens%20On%20Endometrial%20Safety%20And%20Postmenopausal%20Osteoporosis"]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":445},"commonTop":["Headache","Nasopharyngitis","Back pain","Pain in extremity","Arthralgia"]}}